ADVERSE INFLUENCE OF RECIPIENT LYMPHOID RESISTANCE TO IN VITRO IMMUNOSUPPRESSION ON THE OUTCOME OF KIDNEY TRANSPLANTS

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Transplantation

• Publication date

  1988-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-198812000-00012PMID 2974655
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclosporin A and prednisolone do not inhibit the expression of high-affinity receptors for interleukin 2.

  1988cited by this paper
• Blood transfusion induction of immunosuppressant-resistant lymphoid populations in dialysis patients.

  1987cited by this paper
• Interleukin 2 synthesis in the presence of steroids: a model of steroid resistance.

  1987cited by this paper
• Pretransplant lymphocyte sensitivity to methylprednisolone.

  1986cited by this paper
• Induction of steroid-resistant lymphoid populations in renal dialysis patients: association with pretransplant transfusion.

  1986cited by this paper
• Recipient lymphocyte sensitivity to methylprednisolone affects cadaver kidney graft survival.

  1986cited by this paper
• Vesicoureteric reflux: segregation analysis.

  1985cited by this paper
• Antithymocyte globulin-induced prolongation of human renal allograft survival in recipients with in vitro steroid-resistant ADCC.

  1984cited by this paper
• Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen

  1984cited by this paper
• Correlation between ADCC resistance to in vitro steroid and renal allograft failure.

  1981cited by this paper
• T cell growth factor receptors. Quantitation, specificity, and biological relevance

  1981cited by this paper
• In search of marker for genetic susceptibility to reflux nephropathy.

  1980cited by this paper
• Tubulointerstitial immune complex nephritis in rats immunized with Tamm-Horsfall protein.

  1980cited by this paper
• Pathophysiology of Tamm-Horsfall protein.

  1979cited by this paper
• HLA and coeliac disease.

  1978cited by this paper
• HLA and liver disease.

  1978cited by this paper
• Histocompatibility antigens in urinary tract infection and vesicoureteral reflux: a preliminary communication.

  1978cited by this paper
• Stimulation of human peripheral blood lymphocytes by Tamm-Horsfall urinary glycoprotein.

  1978cited by this paper
• The major histocompatibility system and the immune response.

  1978cited by this paper
• A MUCOPROTEIN DERIVED FROM HUMAN URINE WHICH REACTS WITH INFLUENZA, MUMPS, AND NEWCASTLE DISEASE VIRUSES

  1951cited by this paper

• The IMBG Test for Evaluating the Pharmacodynamic Response to Immunosuppressive Therapy in Kidney Transplant Patients: Current Evidence and Future Applications

  2023cites this paper
• The Immunobiogram, a Novel In Vitro Assay to Evaluate Treatment Resistance in Patients Receiving Immunosuppressive Therapy

  2021cites this paper
• Evaluation of three different laboratory methods to detect preformed human leukocyte antigen antibodies in a South African kidney transplant population

  2021cites this paper
• Spontaneous renal allograft rupture: a disappearing phenomenon in the cyclosporine era?

  2010cites this paper
• Clinical Significance of the Cellular Pharmacodynamics of Tacrolimus in Living-Donor Liver Transplantation

  2009cites this paper
• Cyclosporine pharmacological efficacy estimated by lymphocyte immunosuppressant sensitivity test before and after renal transplantation

  2009cites this paper
• Cellular pharmacodynamics of immunosuppressive drugs for individualized medicine.

  2007cites this paper
• Pretransplant Mixed Lymphocyte Culture Still Has an Impact on Graft Survival

  2004cites this paper
• Constitutive and acquired resistance to calcineurin inhibitors in renal transplantation: role of P-glycoprotein-170

  2000cites this paper
• Constitutive and acquired resistance to calcineurin inhibitors in renal transplantation: role of P‐glycoprotein‐170

  2000cites this paper
• Relationship between Lymphocyte and Clinical Steroid Responsiveness in Focal Segmental Glomerulosclerosis

  2000cites this paper
• Cyclosporine A sensitivity in vitro and P-glycoprotein expression in patients on dialysis and after kidney transplantation.

  2000cites this paper
• Lymphocyte Suppression by Glucocorticoids with Cyclosporine, Tacrolimus, Pentoxifylline, and Mycophenolic Acid

  1999cites this paper
• Pretransplant MLC in the presence of cyclosporine may predict renal allograft survival.

  1999cites this paper
• Tacrolimus-induced apoptosis and its prevention by interleukins in mitogen-activated human peripheral-blood mononuclear cells.

  1998cites this paper
• Immunosuppressant pharmacodynamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis, and psoriasis: Possible implications for individual therapeutic efficacy

  1997cites this paper
• Glucocorticoids and cyclosporine induce apoptosis in mitogen-activated human peripheral mononuclear cells.

  1997cites this paper
• Differential Glucocorticoid Responsiveness of Hemoclialysis Patients' Lymphocytes

  1997cites this paper
• Heterogeneity of dialysis patient lymphocyte responses to cyclosporine.

  1996cites this paper
• Differential glucocorticoid responsiveness of dialysis patients' lymphocytes.

  1996cites this paper
• Lymphocyte Responsiveness to Glucocorticoids, Cyclosporine, or Both

  1996cites this paper
• Differential Glucocorticoid Responsiveness of Dialysis Patients’ Lymphocytes

  1996cites this paper
• Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin A.

  1996cites this paper
• Relevance of pretransplant donor-specific T cell allorepertoire for human kidney graft survival.

  1995cites this paper
• Gramicidin as a potential immunosuppressant for organ transplantation: suppression of human lymphocyte blastogenesis in vitro and prolongation of heart allograft survival in the rat.

  1995cites this paper
• In vitro response to immunosuppressive agents in blacks.

  1993cites this paper
• Kidney transplantation from living related donors: a 19‐year experience

  1993cites this paper
• Implications of lymphocyte sensitivity to glucocorticoids in renal transplant recipients.

  1993cites this paper
• DIFFERENTIAL INHIBITION OF PRIMED ALLOREACTIVE CTLs IN VITRO BY CLINICALLY USED CONCENTRATIONS OF CYCLOSPORINE AND FK506

  1993cites this paper
• Inhibition of PHA induced mononuclear cell proliferation by FK506 in combination with cyclosporine, methylprednisolone, 6-mercaptopurine and mycophenolic acid.

  1993cites this paper
• Toward a Rational Design of Clinical Trials of Immunosuppressive Agents in Transplantation

  1993cites this paper
• Appropriate allocation of pediatric donor kidneys

  1993cites this paper
• Analyzing the number of "rejection episodes" in renal transplant studies.

  1992cites this paper
• Renal transplantation using a continent ileocecal urinary reservoir as a bladder substitute.

  1992cites this paper
• Living-related and living-unrelated kidney transplantation using low-dose triple immunosuppression.

  1992cites this paper
• A study of the time course of induction of class II and interleukin-2 receptors on human lymphocytes in response to alloantigen.

  1991cites this paper
• Utility of an in vitro immunoassay to guide immunosuppressive therapy.

  1991cites this paper
• Preoperative identification of high-risk recipients of first kidney transplants by in vitro lymphocyte resistance to immunosuppressive agents.

  1991cites this paper
• Inhibition of PHA lymphocyte responses by cyclosporine and methylprednisolone.

  1990cites this paper
• The immunosuppressive properties of new oral prostaglandin E1 analogs.

  1990cites this paper
• Analysis of the interactions of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation.

  1990cites this paper
• Increased frequency of kidney allograft rejection in recipients with cyclosporine and/or steroid-resistant lymphoid responses.

  1990cites this paper
• Prostaglandin E1 and E2 suppression of in vitro lymphoid responses to alloantigen.

  1989cites this paper